The HIV-1 Nef appears to inhibit the activation of transcription factors NF-KB and AP-1 in T-cells by interfering with the TCR-CD3 signaling pathway. The c-Raf-1 kinase integrates upstream activation signals emanating from receptor tyrosine kinases, PKC, and p21Ras with the MAP kinase and NF-KB signaling pathways, and has also been shown to activate physical association between the HIV-1 Nef protein and the c-Raf-1/Mek-1 kinase complex in vitro and in the chronically-infected CEM-SS cell line. The specific site of interaction in vitro was mapped by deletion mutagenesis to a minimal 12-amino acid sequence, Leu-His-Pro-Val-Ser-Leu-His-Gly-Met-Asp-Asp-Pro, represented by residues 165-176 at the carboxy terminal region of Nef. We found that individual or dual substitution of the conserved Asp 174 and Asp175 residues in the full-length GST-Nef sequence, completely abrogated the in vitro binding of c-Raf-1 to Nef. In a recent study, mutation of the highly-conserved di-aspartic acid motif (Asp174 and Asp175), produced the only fully stable Nef protein incapable of down-regulating the CD4 receptor. The di-aspartic acid residues are highly conserved among the different HIV-1 Nef proteins, as well as between HIV-2 and SIV Nef proteins. Furthermore, these residues (Asp/Gly-Asp-Pro-Glu-Arg-Glu 174-179), bear strong similarity to the sequence Asp-Pro-Thr-Ile-Glu-Asp (residues 33-38), at the known c-Raf-1 binding site within the effector loop of the p21Ras oncoprotein. Recent crystallographic data of the putative c-Raf-1 binding region of Nef reveals a large loop, which extends outward from the main structural domains of Nef, indicating its highly-charged residues could easily participate in protein-protein interactions. Our preliminary data also shows approximately a dozen unidentified proteins that associate directly or indirectly with Nef GST-fusion proteins. These interactions survive treatment with 300 mM NaCl, and may yield further important data regarding the interaction of Nef with cellular proteins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005120-17
Application #
2463601
Study Section
Special Emphasis Panel (LMO)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code